Source: Betakit

Spiderwort: Spiderwort closes $3.4 million CAD in seed financing

Spiderwort, an Ottawa-based healthtech and biomaterials startup, has raised a seed round of funding at $3.4 million CAD ($2.5 million USD). The round was...

Read full article »

Spiderwort's Competitors | Spiderwort's News | Spiderwort's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

Co-Founder & CEO

Charles M. Cuerrier

CEO Approval Rating

86/100

Spiderwort is a Canada-based biotechnology company that develops and commercializes novel cellulose biomaterials for the treatment of soft tissue replacement.